Plasmodium falciparumandPlasmodium yoelii:Effect of the Iron Chelation Prodrug Dexrazoxane onin VitroCultures

This publication has 17 references indexed in Scilit:

• Transport of iron and other transition metals into cells as revealed by a fluorescent probe
  American Journal of Physiology-Cell Physiology, 1995
• Ferrous Ion Strongly Promotes the Ring Opening of the Hydrolysis Intermediates of the Antioxidant Cardioprotective Agent Dexrazoxane (ICRF-187)
  Archives of Biochemistry and Biophysics, 1995
• The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes
  Inflammation Research, 1993
• Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria
  New England Journal of Medicine, 1992
• Characterization of the Aqueous Decomposition Products of (+)1,2-bis(3,5-Dioxopiperazinyl-1-yl)-propane (ICRF-187) by Liquid Chromatographic and Mass Spectral Analysis
  Journal of Pharmaceutical Sciences, 1991
• The interaction of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin
  Inflammation Research, 1989
• RECENT TRENDS IN THE EPIDEMIOLOGY AND CONTROL OF MALARIA1
  Epidemiologic Reviews, 1987
• Bovine liver dihydropyrimidine amidohydrolase: Purification, properties, and characterization as a zinc metalloenzyme
  Archives of Biochemistry and Biophysics, 1983
• Studies on the stability and cellular distribution of dioxopiperazines in cultured BHK-21S cells
  Biochemical Pharmacology, 1975
• Chelation of Ferrous Sulphate Solutions by Desferrioxamine B
  Nature, 1965